MIR145

5q minus syndrome

The MIR145 gene is involved in a condition called 5q minus (5q-) syndrome. This condition is a type of bone marrow disorder called myelodysplastic syndrome (MDS), in which immature blood cells fail to develop normally. Individuals with 5q- syndrome often have a shortage of red blood cells (anemia) and abnormalities in megakaryocytes. Affected individuals also have an increased risk of developing a fast-growing blood cancer known as acute myeloid leukemia (AML).

5q- syndrome is caused by deletion of a region of DNA from the long (q) arm of chromosome 5. This deletion occurs in immature blood cells during a person's lifetime and affects one copy of chromosome 5 in each cell. Most people with 5q- syndrome are missing a sequence of about 1.5 million DNA building blocks (base pairs), also written as 1.5 megabases (Mb). This deleted region contains 40 genes, including MIR145. Loss of one copy of the MIR145 gene reduces the amount of the microRNA miR-145 in cells. As a result, levels of proteins whose production is normally blocked by miR-145 are elevated, which leads to the abnormal development of megakaryocytes that occurs in 5q- syndrome. Research suggests that the other features of the condition are associated with other genes in the deleted segment of DNA.